Lexaria Bioscience News

Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Exercise and Issuance

KELOWNA, BC / ACCESSWIRE / April 30, 2024 / Lexaria Bioscience Corp. , a global innovator in drug delivery platforms announces it has entered

AccesswireApr 30 15:40 ET

Lexaria Bioscience, Biosig Technologies, BIMI Holdings Among Healthcare Movers

Seeking AlphaApr 17 10:00 ET

12 Health Care Stocks Moving In Tuesday's After-Market Session

GainersClene (NASDAQ:CLNN) shares moved upwards by 54.9% to $0.48 during Tuesday's after-market session. The company's market cap stands at $61.6 million. Talphera (NASDAQ:TLPH) shares moved upwards b

BenzingaApr 16 16:31 ET

Express News | Lexaria Bioscience - Subject Recruitment to Begin Immediately & Co to Announce as Soon as First Dosing Has Begun, Expected Within 30 Days or Less

Moomoo 24/7Apr 16 09:15 ET

Express News | Lexaria Bioscience Corp: Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study

Moomoo 24/7Apr 16 09:14 ET

Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study

Human Pilot Study #2 Approved KELOWNA, BC / ACCESSWIRE / April 16, 2024 / Lexaria Bioscience Corp. , a global innovator in drug

AccesswireApr 16 09:10 ET

Lexaria Awarded New Patents

Lexaria receives new patents in the fields of epilepsy and anti-viral agentsKELOWNA, BC / ACCESSWIRE / April 2, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria")

AccesswireApr 2 09:00 ET

Lexaria Bioscience Showcases Drug Delivery Breakthrough

TipRanksMar 21 13:07 ET

Lexaria to Present at The LD Micro Invitational XIV

Yahoo FinanceMar 21 09:20 ET

Lexaria Bioscience Welcomes New CFO

TipRanksMar 14 12:37 ET

Lexaria Appoints Nelson Cabatuan as Chief Financial Officer, Effective Immediately

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the appointment of Nelson Cabatuan, CPA, as Chief Financial O

BenzingaMar 14 09:22 ET

Lexaria Bioscience Files to Sell 1.61M Shares of Common Stock for Holders

Seeking AlphaMar 12 17:20 ET

12 Health Care Stocks Moving In Tuesday's Intraday Session

GainersRegulus Therapeutics (NASDAQ:RGLS) stock increased by 94.9% to $2.69 during Tuesday's regular session. The company's market cap stands at $54.3 million. Bright Green (NASDAQ:BGXX) shares increa

BenzingaMar 12 13:31 ET

FGEN, LEXX and SGLY Among Mid-day Movers

Seeking AlphaMar 12 12:21 ET

Lexaria Bioscience Advances Oral Diabetes Treatment

TipRanksMar 7 13:37 ET

Express News | Lexaria Bioscience Hires Contract Research Organization To Perform Co.'s Next GLP-1 Human Pilot Study

Moomoo 24/7Mar 7 09:08 ET

Sector Update: Health Care Stocks Retreating Late Afternoon

Health care stocks fell late Tuesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each dropping about 1%. The iShares Biotechnology ETF (IBB) slumped 1.

MT NewswiresMar 5 15:59 ET

Sector Update: Health Care

Health care stocks fell late Tuesday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each dropping about 1%. The iShares Biotechnology ETF (IBB) fell 1.1%.

MT NewswiresMar 5 15:33 ET

Lexaria to Test DehydraTECH GLP-1 Product for Weight Loss, Diabetes

Seeking AlphaMar 5 12:39 ET

Lexaria Bioscience Is Maintained at Buy by Maxim Group

Lexaria Bioscience Is Maintained at Buy by Maxim Group

Dow JonesMar 5 11:49 ET